Your browser doesn't support javascript.
loading
Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein.
Doyle, Michael P; Kose, Nurgun; Borisevich, Viktoriya; Binshtein, Elad; Amaya, Moushimi; Nagel, Marcus; Annand, Edward J; Armstrong, Erica; Bombardi, Robin; Dong, Jinhui; Schey, Kevin L; Broder, Christopher C; Zeitlin, Larry; Kuang, Erin A; Bornholdt, Zachary A; West, Brandyn R; Geisbert, Thomas W; Cross, Robert W; Crowe, James E.
Affiliation
  • Doyle MP; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Kose N; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Borisevich V; Department of Microbiology & Immunology, The University of Texas Medical Branch, Galveston, TX 77555, USA; Galveston National Laboratory, The University of Texas Medical Branch, Galveston, TX 77555, USA.
  • Binshtein E; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Amaya M; Department of Microbiology & Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
  • Nagel M; Department of Biochemistry, Vanderbilt University, Nashville, TN 37232, USA.
  • Annand EJ; Sydney School of Veterinary Science and Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Sydney, Australia; Black Mountain Laboratories & Australian Centre for Disease Preparedness, Health and Biosecurity, CSIRO, Canberra & Geelong, Australia.
  • Armstrong E; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Bombardi R; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Dong J; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
  • Schey KL; Department of Biochemistry, Vanderbilt University, Nashville, TN 37232, USA.
  • Broder CC; Department of Microbiology & Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
  • Zeitlin L; Mapp Biopharmaceutical, Inc., San Diego, CA 92121, USA.
  • Kuang EA; Mapp Biopharmaceutical, Inc., San Diego, CA 92121, USA.
  • Bornholdt ZA; Mapp Biopharmaceutical, Inc., San Diego, CA 92121, USA.
  • West BR; Mapp Biopharmaceutical, Inc., San Diego, CA 92121, USA.
  • Geisbert TW; Department of Microbiology & Immunology, The University of Texas Medical Branch, Galveston, TX 77555, USA; Galveston National Laboratory, The University of Texas Medical Branch, Galveston, TX 77555, USA.
  • Cross RW; Department of Microbiology & Immunology, The University of Texas Medical Branch, Galveston, TX 77555, USA; Galveston National Laboratory, The University of Texas Medical Branch, Galveston, TX 77555, USA.
  • Crowe JE; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, US
Cell Rep ; 36(9): 109628, 2021 08 31.
Article de En | MEDLINE | ID: mdl-34469726
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Antiviraux / Récepteurs viraux / Éphrine B2 / Éphrine B3 / Henipavirus / Infections à hénipavirus / Anticorps neutralisants / Anticorps monoclonaux Type d'étude: Prognostic_studies Limites: Animals / Female / Humans Langue: En Journal: Cell Rep Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Antiviraux / Récepteurs viraux / Éphrine B2 / Éphrine B3 / Henipavirus / Infections à hénipavirus / Anticorps neutralisants / Anticorps monoclonaux Type d'étude: Prognostic_studies Limites: Animals / Female / Humans Langue: En Journal: Cell Rep Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique